BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 20729466)

  • 1. Acquired genomic copy number aberrations and survival in adult acute myelogenous leukemia.
    Parkin B; Erba H; Ouillette P; Roulston D; Purkayastha A; Karp J; Talpaz M; Kujawski L; Shakhan S; Li C; Shedden K; Malek SN
    Blood; 2010 Dec; 116(23):4958-67. PubMed ID: 20729466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
    Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
    Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated genomic profiling, therapy response, and survival in adult acute myelogenous leukemia.
    Parkin B; Ouillette P; Yildiz M; Saiya-Cork K; Shedden K; Malek SN
    Clin Cancer Res; 2015 May; 21(9):2045-56. PubMed ID: 25652455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of previously cryptic copy number alterations and loss of heterozygosity in pediatric acute myeloid leukemia and myelodysplastic syndrome determined using combined array comparative genomic hybridization plus single-nucleotide polymorphism microarray analyses.
    Koh KN; Lee JO; Seo EJ; Lee SW; Suh JK; Im HJ; Seo JJ
    J Korean Med Sci; 2014 Jul; 29(7):926-33. PubMed ID: 25045224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of acquired copy-neutral loss of heterozygosity in acute myeloid leukemia.
    Gronseth CM; McElhone SE; Storer BE; Kroeger KA; Sandhu V; Fero ML; Appelbaum FR; Estey EH; Fang M
    Cancer; 2015 Sep; 121(17):2900-8. PubMed ID: 26033747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Array-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: performance comparison of Affymetrix 10K2.0, 250K Nsp, and SNP6.0 arrays.
    Hagenkord JM; Monzon FA; Kash SF; Lilleberg S; Xie Q; Kant JA
    J Mol Diagn; 2010 Mar; 12(2):184-96. PubMed ID: 20075210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of acquired genomic copy number aberrations and regions of loss of heterozygosity in acute myelogenous leukemia genomes using Affymetrix SNP 6.0 arrays and supporting software tools.
    Ouillette PD; Shedden KA; Li C; Malek SN
    Methods Mol Biol; 2013; 973():99-119. PubMed ID: 23412786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia.
    Ouillette P; Collins R; Shakhan S; Li J; Peres E; Kujawski L; Talpaz M; Kaminski M; Li C; Shedden K; Malek SN
    Blood; 2011 Sep; 118(11):3051-61. PubMed ID: 21795749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF1 inactivation in adult acute myelogenous leukemia.
    Parkin B; Ouillette P; Wang Y; Liu Y; Wright W; Roulston D; Purkayastha A; Dressel A; Karp J; Bockenstedt P; Al-Zoubi A; Talpaz M; Kujawski L; Liu Y; Shedden K; Shakhan S; Li C; Erba H; Malek SN
    Clin Cancer Res; 2010 Aug; 16(16):4135-47. PubMed ID: 20505189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of clinically important chromosomal aberrations in acute myeloid leukemia by array-based comparative genomic hybridization.
    Mehrotra M; Luthra R; Ravandi F; Sargent RL; Barkoh BA; Abraham R; Mishra BM; Medeiros LJ; Patel KP
    Leuk Lymphoma; 2014 Nov; 55(11):2538-48. PubMed ID: 24446873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of genetic aberrations in secondary acute myeloid leukemia.
    Milosevic JD; Puda A; Malcovati L; Berg T; Hofbauer M; Stukalov A; Klampfl T; Harutyunyan AS; Gisslinger H; Gisslinger B; Burjanivova T; Rumi E; Pietra D; Elena C; Vannucchi AM; Doubek M; Dvorakova D; Robesova B; Wieser R; Koller E; Suvajdzic N; Tomin D; Tosic N; Colinge J; Racil Z; Steurer M; Pavlovic S; Cazzola M; Kralovics R
    Am J Hematol; 2012 Nov; 87(11):1010-6. PubMed ID: 22887079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal aberrations in 17p predict in vitro drug resistance and short overall survival in acute myeloid leukemia.
    Nahi H; Lehmann S; Bengtzen S; Jansson M; Möllgård L; Paul C; Merup M
    Leuk Lymphoma; 2008 Mar; 49(3):508-16. PubMed ID: 18297528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Older patients with normal karyotype acute myeloid leukemia have a higher rate of genomic changes compared to young patients as determined by SNP array analysis.
    Koren-Michowitz M; Sato-Otsubo A; Nagler A; Haferlach T; Ogawa S; Koeffler HP
    Leuk Res; 2012 Apr; 36(4):467-73. PubMed ID: 22071139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New lesions detected by single nucleotide polymorphism array-based chromosomal analysis have important clinical impact in acute myeloid leukemia.
    Tiu RV; Gondek LP; O'Keefe CL; Huh J; Sekeres MA; Elson P; McDevitt MA; Wang XF; Levis MJ; Karp JE; Advani AS; Maciejewski JP
    J Clin Oncol; 2009 Nov; 27(31):5219-26. PubMed ID: 19770377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additional genomic aberrations identified by single nucleotide polymorphism array-based karyotyping in an acute myeloid leukemia case with isolated del(20q) abnormality.
    Hahm C; Mun YC; Seong CM; Chung WS; Huh J
    Ann Lab Med; 2012 Nov; 32(6):445-9. PubMed ID: 23130347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-nucleotide polymorphism-array improves detection rate of genomic alterations in core-binding factor leukemia.
    Costa AR; Vasudevan A; Krepischi A; Rosenberg C; Chauffaille Mde L
    Med Oncol; 2013; 30(2):579. PubMed ID: 23636907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Applications of Chromosomal Microarray Testing in Myeloid Malignancies.
    Ronaghy A; Yang RK; Khoury JD; Kanagal-Shamanna R
    Curr Hematol Malig Rep; 2020 Jun; 15(3):194-202. PubMed ID: 32382988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single nucleotide polymorphism array-based karyotyping in acute myeloid leukemia or myelodysplastic syndrome with trisomy 8 as the sole chromosomal abnormality.
    Hahm C; Mun YC; Seong CM; Han SH; Chung WS; Huh J
    Acta Haematol; 2013; 129(3):154-8. PubMed ID: 23208021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH.
    Schoch C; Haferlach T; Bursch S; Gerstner D; Schnittger S; Dugas M; Kern W; Löffler H; Hiddemann W
    Genes Chromosomes Cancer; 2002 Sep; 35(1):20-9. PubMed ID: 12203786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of SNP Array Abnormalities in Patients with DE NOVO Acute Myeloid Leukemia with Normal Karyotype.
    Ibáñez M; Such E; Onecha E; Gómez-Seguí I; Liquori A; Sellés J; Hervás-Marín D; Barragán E; Ayala R; LLop M; López-Pavía M; Rapado I; Neef A; Sanjuan-Pla A; Sargas C; Gonzalez-Romero E; Boluda-Navarro M; Andreu R; Senent L; Montesinos P; Martínez-López J; Angel Sanz M; Sanz G; Cervera J
    Sci Rep; 2020 Apr; 10(1):5904. PubMed ID: 32246042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.